1.
Estimating measures of interaction on an additive scale for preventive exposures
by Knol, M.J
European journal of epidemiology, 2011, Vol.26 (6), p.433-438
2.
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
by Jun, Min, MSc
The Lancet (British edition), 2010, Vol.375 (9729), p.1875-1884
3.
Risk prediction models: II. External validation, model updating, and impact assessment
by Moons, Karel G M
Heart, 2012, Vol.98 (9), p.691-698
4.
Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker
by Moons, Karel G M
Heart, 2012, Vol.98 (9), p.683-690
5.
Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials
by Heerspink, Hiddo J Lambers, PharmD
The Lancet (British edition), 2009, Vol.373 (9668), p.1009-1015
6.
The (mis)use of overlap of confidence intervals to assess effect modification
by Knol, Mirjam J
European journal of epidemiology, 2011, Vol.26 (4), p.253-254
7.
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
by Kahn, René S, Prof
The Lancet (British edition), 2008, Vol.371 (9618), p.1085-1097
8.
Series: Pragmatic trials and real world evidence: Paper 1. Introduction
by Zuidgeest, Mira G.P
Journal of clinical epidemiology, 2017, Vol.88, p.7-13
9.
Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study
by Hermans, Lucas E
The Lancet infectious diseases, 2018, Vol.18 (2), p.188-197
10.
Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial
by Bots, Michiel L, Dr
The Lancet (British edition), 2007, Vol.370 (9582), p.153-160
11.
12.
Missing covariate data in medical research: To impute is better than to ignore
by Janssen, Kristel J.M
Journal of clinical epidemiology, 2010, Vol.63 (7), p.721-727
13.
PRECIS-2 in perspective: what is next for pragmatic trials?
by Zuidgeest, Mira G
Journal of clinical epidemiology, 2016, Vol.84, p.22-24
14.
Social Burden and Lifestyle in Adults With Congenital Heart Disease
by Zomer, A. Carla, MD
The American journal of cardiology, 2012, Vol.109 (11), p.1657-1663
15.
Sodium and potassium intake and risk of cardiovascular events and all-cause mortality: the Rotterdam Study
by Geleijnse, JM
European journal of epidemiology, 2007, Vol.22 (11), p.763-770
16.
Series: Pragmatic trials and real world evidence: Paper 3. Patient selection challenges and consequences
by Oude Rengerink, Katrien
Journal of clinical epidemiology, 2017, Vol.89, p.173-180
17.
A public health evaluation of 13-valent pneumococcal conjugate vaccine impact on adult disease outcomes from a randomized clinical trial in the Netherlands
by Gessner, Bradford D
Vaccine, 2019, Vol.37 (38), p.5777-5787
18.
The prediction of functional decline in older hospitalised patients
by Hoogerduijn, Jita G
Age and ageing, 2012, Vol.41 (3), p.381-387
19.
Post-hoc analysis of a randomized controlled trial: Diabetes mellitus modifies the efficacy of the 13-valent pneumococcal conjugate vaccine in elderly
by Huijts, Susanne M
Vaccine, 2017, Vol.35 (34), p.4444-4449
20.
Selection of confounding variables should not be based on observed associations with exposure
by Groenwold, Rolf H. H
European journal of epidemiology, 2011, Vol.26 (8), p.589-593
